COUNCIL REGULATION (EC) No 129/2007 of 12 February 2007 providing for duty-free treatment for specified pharmaceutical active ingredients bearing an ‘international non-proprietary name’ (INN) from the World Health Organisation and specified products used for the manufacture of finished pharmaceuticals and amending Annex I to Regulation (EEC) No 2658/87 ANNEX I List of international non-proprietary names (INNs) to be added to the list of products receiving duty-free treatment included in Annex 3 to Commission Regulation (EC) No 1549/2006 ANNEX II List of prefixes and suffixes which, in combination with the INNs of Annex 3 to Regulation (EC) No 1549/2006, describe the salts, esters or hydrates of INNs; these salts, esters and hydrates are free of duty, on condition that they are classifiable in the same six-digit HS-subheading as the corresponding INN ANNEX III List of pharmaceutical intermediates, i.e. compounds used for the manufacture of finished pharmaceutical products, to be added to the list of products receiving duty-free treatment included in Annex 6 to Regulation (EC) No 1549/2006 ANNEX IV List of pharmaceutical intermediates, i.e. compounds used for the manufacture of finished pharmaceutical products, to be withdrawn from the list of products receiving duty-free treatment included in Annex 6 to Regulation (EC) No 1549/2006

COUNCIL REGULATION (EC) No 129/2007 of 12 February 2007 providing for duty-free treatment for specified pharmaceutical active ingredients bearing an ‘international non-proprietary name’ (INN) from the World Health Organisation and specified products used for the manufacture of finished pharmaceuticals and amending Annex I to Regulation (EEC) No 2658/87 ANNEX I List of international non-proprietary names (INNs) to be added to the list of products receiving duty-free treatment included in Annex 3 to Commission Regulation (EC) No 1549/2006 ANNEX II List of prefixes and suffixes which, in combination with the INNs of Annex 3 to Regulation (EC) No 1549/2006, describe the salts, esters or hydrates of INNs; these salts, esters and hydrates are free of duty, on condition that they are classifiable in the same six-digit HS-subheading as the corresponding INN ANNEX III List of pharmaceutical intermediates, i.e. compounds used for the manufacture of finished pharmaceutical products, to be added to the list of products receiving duty-free treatment included in Annex 6 to Regulation (EC) No 1549/2006 ANNEX IV List of pharmaceutical intermediates, i.e. compounds used for the manufacture of finished pharmaceutical products, to be withdrawn from the list of products receiving duty-free treatment included in Annex 6 to Regulation (EC) No 1549/2006eu-regulation-2007-x-x-129